To further explore the myeloid phenotypes present in SB28 tumors grown intracerebrally or subcutaneously, we examined the coexpression of PD-L1, CD206, and MHC-II on tumor-infiltrating CD11b+ myeloid cells. This evidence concerns the gene MRC1 and neoplasm.